164 related articles for article (PubMed ID: 8176716)
21. The 4',4'-difluoro analog of 5'-noraristeromycin: a new structural prototype for possible antiviral drug development toward orthopoxvirus and cytomegalovirus.
Roy A; Schneller SW; Keith KA; Hartline CB; Kern ER
Bioorg Med Chem; 2005 Jul; 13(14):4443-9. PubMed ID: 15908221
[TBL] [Abstract][Full Text] [Related]
22. 6'-Fluoro-3-deazaneplanocin: Synthesis and antiviral properties, including Ebola.
Liu C; Chen Q; Cardinale S; Bowlin TL; Schneller SW
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3674-3675. PubMed ID: 30385162
[TBL] [Abstract][Full Text] [Related]
23. Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.
Chandra G; Moon YW; Lee Y; Jang JY; Song J; Nayak A; Oh K; Mulamoottil VA; Sahu PK; Kim G; Chang TS; Noh M; Lee SK; Choi S; Jeong LS
J Med Chem; 2015 Jun; 58(12):5108-20. PubMed ID: 26010585
[TBL] [Abstract][Full Text] [Related]
24. Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase.
De Clercq E; Cools M; Balzarini J
Biochem Pharmacol; 1989 Jun; 38(11):1771-8. PubMed ID: 2735935
[TBL] [Abstract][Full Text] [Related]
25. 3'-Fluoro-3'-deoxy-5'-noraristeromycin derivatives: synthesis and antiviral analysis.
Roy A; Serbessa T; Schneller SW
Bioorg Med Chem; 2006 Jul; 14(14):4980-6. PubMed ID: 16581253
[TBL] [Abstract][Full Text] [Related]
26. C-3 halo and 3-methyl substituted 5'-nor-3-deazaaristeromycins: synthesis and antiviral properties.
Liu C; Chen Q; Yang M; Schneller SW
Bioorg Med Chem; 2013 Jan; 21(1):359-64. PubMed ID: 23176752
[TBL] [Abstract][Full Text] [Related]
27. A new synthesis and an antiviral assessment of the 4'-fluoro derivative of 4'-deoxy-5'-noraristeromycin.
Yin XQ; Li WK; Yang M; Schneller SW
Bioorg Med Chem; 2009 Apr; 17(8):3126-9. PubMed ID: 19329326
[TBL] [Abstract][Full Text] [Related]
28. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase.
Borcherding DR; Narayanan S; Hasobe M; McKee JG; Keller BT; Borchardt RT
J Med Chem; 1988 Sep; 31(9):1729-38. PubMed ID: 3411600
[TBL] [Abstract][Full Text] [Related]
29. 3-Bromo-3-deazaneplanocin and 3-bromo-3-deazaaristeromycin: synthesis and antiviral activity.
Liu C; Chen Q; Schneller SW
Bioorg Med Chem Lett; 2012 Aug; 22(16):5182-4. PubMed ID: 22795626
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiviral evaluation of 6'-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase.
Madhavan GV; McGee DP; Rydzewski RM; Boehme R; Martin JC; Prisbe EJ
J Med Chem; 1988 Sep; 31(9):1798-804. PubMed ID: 2842505
[TBL] [Abstract][Full Text] [Related]
31. The enantiomers of carbocyclic 5'-norguanosine: activity towards Epstein-Barr virus.
Rajappan V; Schneller SW; Williams SL; Kern ER
Bioorg Med Chem; 2002 Apr; 10(4):883-6. PubMed ID: 11836094
[TBL] [Abstract][Full Text] [Related]
32. Enantiomeric 3-deaza-1',6'-isoneplanocin and its 3-bromo analogue: Synthesis by the Ullmann reaction and their antiviral properties.
Liu C; Chen Q; Schneller SW
Bioorg Med Chem Lett; 2016 Feb; 26(3):928-930. PubMed ID: 26750250
[TBL] [Abstract][Full Text] [Related]
33. Sugar-modified conjugated diene analogues of adenosine and uridine: synthesis, interaction with S-adenosyl-L-homocysteine hydrolase, and antiviral and cytostatic effects.
Wnuk SF; Ro BO; Valdez CA; Lewandowska E; Valdez NX; Sacasa PR; Yin D; Zhang J; Borchardt RT; De Clercq E
J Med Chem; 2002 Jun; 45(12):2651-8. PubMed ID: 12036374
[TBL] [Abstract][Full Text] [Related]
34. Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives?
Seley KL; Schneller SW; Korba B
J Med Chem; 1998 Jun; 41(12):2168-70. PubMed ID: 9622558
[TBL] [Abstract][Full Text] [Related]
35. Alkyl esters of 3-adenin-9-yl-2-hydroxypropanoic acid: a new class of broad-spectrum antiviral agents.
De Clercq E; Holý A
J Med Chem; 1985 Mar; 28(3):282-7. PubMed ID: 3973900
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral evaluation.
Montagu A; Roy V; Balzarini J; Snoeck R; Andrei G; Agrofoglio LA
Eur J Med Chem; 2011 Feb; 46(2):778-86. PubMed ID: 21232828
[TBL] [Abstract][Full Text] [Related]
37. (+)-7-Deaza-5'-noraristeromycin as an anti-trypanosomal agent.
Seley KL; Schneller SW; Rattendi D; Bacchi CJ
J Med Chem; 1997 Feb; 40(4):622-4. PubMed ID: 9046353
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activities of 8-alkynyl-, 8-alkenyl-, and 8-alkyl-2'-deoxyadenosine analogues.
Sági G; Otvös L; Ikeda S; Andrei G; Snoeck R; De Clercq E
J Med Chem; 1994 Apr; 37(9):1307-11. PubMed ID: 8176708
[TBL] [Abstract][Full Text] [Related]
39. Anticancer and antiviral effects and inactivation of S-adenosyl-L-homocysteine hydrolase with 5'-carboxaldehydes and oximes synthesized from adenosine and sugar-modified analogues.
Wnuk SF; Yuan CS; Borchardt RT; Balzarini J; De Clercq E; Robins MJ
J Med Chem; 1997 May; 40(11):1608-18. PubMed ID: 9171871
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiviral activity of 5'-deoxypyrazofurin.
Chen X; Schneller SW; Ikeda S; Snoeck R; Andrei G; Balzarini J; De Clercq E
J Med Chem; 1993 Nov; 36(23):3727-30. PubMed ID: 8246242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
